The role of voriconazole in the treatment of central nervous system blastomycosis

Annals of Pharmacotherapy

Volumn 43, Issue 10, 2009, Pages 1696-1700

  Ta, Mai ^a   Flowers, Stephanie A ^b   Rogers, P David ^b  

^a Casey Hospital   (Australia)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

Author keywords

Blastomycosis; CNS infection; Fungal infection; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

BLASTOMYCOSIS; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; NEPHROTOXICITY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW; SALVAGE THERAPY; SEROLOGY; SIDE EFFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BLASTOMYCES; BLASTOMYCOSIS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 70449462255     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M010     Document Type: Review

References (20)

1. Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008;46:1801-1812
2. Kauffman CA. Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis. Infect Dis Clin North Am 2006;20:645-62, vii.
3. Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003;17:21- 40, vii.
4. Mitchell T. Systemic fungi. In: Cohen J, Powderly WG, eds. Infectious diseases. 2nd ed. London: Mosby, 2004. www.mdconsult.com/das/ book/body/155320863-2/0/1209/717.html
5. Chapman S. Blastomyces dermatitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 6th ed. New York, NY: Churchill Livingstone, 2005:3026-3040
6. Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847-853 (Pubitemid 23034764)
7. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003;37:728-732 (Pubitemid 37100817)
8. Bakleh M, Aksamit AJ, Tleyjeh IM, Marshall WF. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 2005;40:e69-71.
9. Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2006;25:377-379
10. Borgia SM, Fuller JD, Sarabia A, El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006;44:659-664 (Pubitemid 44650518)
11. Freifeld A, Proia L, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009;53:1648-1651
12. Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000;44:1734-1736 (Pubitemid 30340829)
13. Sugar AM, Liu XP. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob Agents Chemother 2001;45:601-604
14. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000;182:274-282
15. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007;45:807-825
16. Pearson GJ, Chin TW, Fong IW. Case report: treatment of blastomycosis with fluconazole. Am J Med Sci 1992;303:313-315
17. Taillan B, Ferrari E, Cosnefroy JY, et al. Favourable outcome of blastomycosis of the brain stem with fluconazole and flucytosine treatment. Ann Med 1992;24:71-72
18. Pappas PG, Bradsher RW, Chapman SW, et al. Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1995;20:267-271
19. Pappas PG, Bradsher RW, Kauffman CA, et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1997;25: 200-205
20. Scott LJ, Simpson D. Voriconazole: a review of its use in the management of invasive fungal infections. Drugs 2007;67:269-298 (Pubitemid 46259330)